Flowr logo

FLWR - Flowr News Story

C$0.26 0.0  0.0%

Last Trade - 10/05/21

Small Cap
Market Cap £52.6m
Enterprise Value £84.0m
Revenue £4.40m
Position in Universe 916th / 2703

The Flowr Corporation Announces Entry into Quebec

Thu 4th February, 2021 11:00am
For best results when printing this announcement, please click on link below:

* The Company shipped its strain BC Pink Kush along with its newest product
offering BC Black Cherry into the Quebec market.
* Expands Flowr’s current reach beyond Ontario, British Columbia and
* Flowr partners with ROSE LifeScience Inc., a local cannabis producer in
TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR;
OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that it
has entered the Province of Quebec with its first commercial orders for its
award-winning BC Pink Kush and its newest strain BC Black Cherry. Flowr has
shipped dried cannabis flower for the first time into the Quebec market
through a distribution partnership with ROSE LifeScience Inc. (“ROSE”).

“We are very pleased to be starting off 2021 with product shipment into the
Quebec marketplace. We are fortunate to have local partners like ROSE
distributing our products and acting as Flowr brand ambassadors on our
behalf,” commented Lance Emanuel, President and Interim Chief Executive
Officer of Flowr. “We believe Quebec will be one of our most important
provincial partners in the future given it is the third largest cannabis
market in Canada to date with approximately 60 dispensaries,” added Mr.

“We are thrilled to bring the brand to Quebecers and to partner with The
Flowr Corporation, a cannabis company with 100% indoor grown
cannabis,” said Davide Zaffino, President and Chief Financial Officer at
ROSE LifeScience Inc.

Flowr entered into a Sales, Marketing and Distribution Agreement (the
“Agreement”) with ROSE in April 2020 and obtained its Autorité des
marchés publics approval to operate in the Province of Quebec in August 2020.
Commercial terms of the Agreement were not disclosed.

Flowr recently won 2020 Brand of the Year at the ADCANN Awards and also took
home a bronze medal at the prestigious Clio Awards. Flowr’s BC Pink Kush was
recently voted by budtenders as the top Indica Dried Flower at the inaugural
Kind Magazine Awards. Flowr’s BC Pink Kush has been a favorite strain and
was a top 10 selling SKU in the dried flower category and the #1 selling SKU
in the Premium Dried Flower category through Q3 2020 in Ontario. BC Pink Kush
has not been irradiated in approximately two years, consistently has both a
high and a tight THC band of 20-25% and terpene content typically in excess of
2.5%, a testament to Flowr’s facility design and growing practices. Thus
far, BC Black Cherry has shown a more robust THC profile than BC Pink Kush and
as a result the Company believes it will be accretive to its revenue growth in

About The Flowr Corporation

The Flowr Corporation is a Toronto-headquartered cannabis company with
operations in Canada, Europe and Australia. Its Canadian operating campus,
located in Kelowna, BC, includes a purpose-built, GMP-designed indoor
cultivation facility; an outdoor and greenhouse cultivation site; and a
state-of-the-art R&D facility. From this campus, Flowr produces recreational
and medicinal products. Internationally, Flowr intends to service the global
medical cannabis market through its subsidiary Holigen, which has a license
for cannabis cultivation in Portugal and operates GMP licensed facilities in
both Portugal and Australia. In 2020, Flowr’s BC Pink Kush was recognized as
the top Indica strain in Canada by Kind Magazine.

Flowr aims to support improving outcomes through responsible cannabis use and,
as an established expert in cannabis cultivation, strives to be the brand of
choice for consumers and patients seeking the highest-quality craftsmanship
and product consistency across a portfolio of differentiated cannabis

For more information, please visit flowrcorp.com
or follow Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr Corporation

About ROSE LifeScience Inc.

As a private Quebec company founded by a group of seasoned executives with
extensive experience in highly regulated industries, ROSE LifeScience is
committed to ensuring that Quebec benefits from the responsible production,
sale and consumption of cannabis. From cannabis cultivation to marketing and
logistics, ROSE plays a key role in the Quebec market. ROSE not only produces
remarkable cannabis, but also offers complete marketing service to selected
producers to encourage a diversified offer on the Quebec market.

On behalf of The Flowr Corporation:
Lance Emanuel
President and Interim Chief Executive Officer


Thierry Elmaleh
Head of Capital Markets
1-877-356-9726 ext. 1528

Forward-Looking Information and Statements

This press release contains “forward-looking information” within the
meaning of Canadian securities laws. Often, but not always, forward-looking
information can be identified by the use of words such as “plans”, “is
expected”, “expects”, “scheduled”, “intends”,
“contemplates”, “anticipates”, “believes”, “proposes” or
variations (including negative and grammatical variations) of such words and
phrases, or state that certain actions, events or results “may”,
“could”, “would”, “might” or “will” be taken, occur or be
achieved. Such information and statements are based on the current
expectations of Flowr’s management and are based on assumptions and subject
to risks and uncertainties. Although Flowr’s management believes that the
assumptions underlying such information and statements are reasonable, they
may prove to be incorrect. The forward-looking events and circumstances
discussed in this press release may not occur by certain specified dates or at
all and could differ materially as a result of known and unknown risk factors
and uncertainties affecting Flowr, including risks relating to: general
economic and stock market conditions; adverse industry events; loss of
markets; future legislative and regulatory developments in Canada and
elsewhere; the cannabis industry in Canada generally; the ability of Flowr to
implement its business strategies; Flowr’s inability to produce or sell
premium quality cannabis, risks and uncertainties detailed from time to time
in Flowr’s filings with the Canadian Securities Administrators; the
Company’s inability to raise capital or have the liquidity to operate or
advance its strategic initiatives and many other factors beyond the control of

Although Flowr has attempted to identify important factors that could cause
actual actions, events or results to differ materially from those described in
forward-looking information or statements, there may be other factors that
cause actions, events or results to differ from those anticipated, estimated
or intended. No forward-looking information or statement can be guaranteed.
Except as required by applicable securities laws, forward-looking information
and statements speak only as of the date on which they are made and Flowr
undertakes no obligation to publicly update or revise any forward-looking
information or statements, whether as a result of new information, future
events or otherwise. When considering such forward-looking information and
statements, readers should keep in mind the risk factors and other cautionary
statements in Flowr’s Annual Information Form dated April 29, 2020 (the
“AIF”) and filed with the applicable securities regulatory authorities in
Canada. The risk factors and other factors noted in the AIF could cause actual
events or results to differ materially from those described in any
forward-looking information or statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.